<?xml version="1.0" encoding="UTF-8"?>
<document id="DrugDDI.d164" origId="Apraclonidine"><sentence id="DrugDDI.d164.s0" origId="s0" text="Apraclonidine should not be used in patients receiving MAO inhibitors.."><entity id="DrugDDI.d164.s0.e0" origId="s0.p0" charOffset="0-13" type="drug" text="Apraclonidine"/><entity id="DrugDDI.d164.s0.e1" origId="s0.p7" charOffset="55-69" type="drug" text="MAO inhibitors"/><pair id="DrugDDI.d164.s0.p0" e1="DrugDDI.d164.s0.e0" e2="DrugDDI.d164.s0.e1" interaction="true"/></sentence><sentence id="DrugDDI.d164.s1" origId="s1" text="Although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of IOPIDINE? 0.5% Ophthalmic Solution, the possibility of an additive or potentiating effect with CNS depressants (alcohol, barbiturates, opiates, sedatives, anesthetics) should be considered."><entity id="DrugDDI.d164.s1.e0" origId="s1.p10" charOffset="61-66" type="drug" text="drugs"/><entity id="DrugDDI.d164.s1.e1" origId="s1.p12" charOffset="79-90" type="drug" text="medications"/><entity id="DrugDDI.d164.s1.e2" origId="s1.p22" charOffset="225-240" type="drug" text="CNS depressants"/><entity id="DrugDDI.d164.s1.e3" origId="s1.p24" charOffset="242-249" type="drug" text="alcohol"/><entity id="DrugDDI.d164.s1.e4" origId="s1.p25" charOffset="251-263" type="drug" text="barbiturates"/><entity id="DrugDDI.d164.s1.e5" origId="s1.p26" charOffset="265-272" type="drug" text="opiates"/><entity id="DrugDDI.d164.s1.e6" origId="s1.p27" charOffset="274-283" type="drug" text="sedatives"/><entity id="DrugDDI.d164.s1.e7" origId="s1.p28" charOffset="285-296" type="drug" text="anesthetics"/><pair id="DrugDDI.d164.s1.p0" e1="DrugDDI.d164.s1.e0" e2="DrugDDI.d164.s1.e1" interaction="false"/><pair id="DrugDDI.d164.s1.p1" e1="DrugDDI.d164.s1.e0" e2="DrugDDI.d164.s1.e2" interaction="false"/><pair id="DrugDDI.d164.s1.p2" e1="DrugDDI.d164.s1.e0" e2="DrugDDI.d164.s1.e3" interaction="false"/><pair id="DrugDDI.d164.s1.p3" e1="DrugDDI.d164.s1.e0" e2="DrugDDI.d164.s1.e4" interaction="false"/><pair id="DrugDDI.d164.s1.p4" e1="DrugDDI.d164.s1.e0" e2="DrugDDI.d164.s1.e5" interaction="false"/><pair id="DrugDDI.d164.s1.p5" e1="DrugDDI.d164.s1.e0" e2="DrugDDI.d164.s1.e6" interaction="false"/><pair id="DrugDDI.d164.s1.p6" e1="DrugDDI.d164.s1.e0" e2="DrugDDI.d164.s1.e7" interaction="false"/><pair id="DrugDDI.d164.s1.p7" e1="DrugDDI.d164.s1.e1" e2="DrugDDI.d164.s1.e2" interaction="false"/><pair id="DrugDDI.d164.s1.p8" e1="DrugDDI.d164.s1.e1" e2="DrugDDI.d164.s1.e3" interaction="false"/><pair id="DrugDDI.d164.s1.p9" e1="DrugDDI.d164.s1.e1" e2="DrugDDI.d164.s1.e4" interaction="false"/><pair id="DrugDDI.d164.s1.p10" e1="DrugDDI.d164.s1.e1" e2="DrugDDI.d164.s1.e5" interaction="false"/><pair id="DrugDDI.d164.s1.p11" e1="DrugDDI.d164.s1.e1" e2="DrugDDI.d164.s1.e6" interaction="false"/><pair id="DrugDDI.d164.s1.p12" e1="DrugDDI.d164.s1.e1" e2="DrugDDI.d164.s1.e7" interaction="false"/><pair id="DrugDDI.d164.s1.p13" e1="DrugDDI.d164.s1.e2" e2="DrugDDI.d164.s1.e3" interaction="false"/><pair id="DrugDDI.d164.s1.p14" e1="DrugDDI.d164.s1.e2" e2="DrugDDI.d164.s1.e4" interaction="false"/><pair id="DrugDDI.d164.s1.p15" e1="DrugDDI.d164.s1.e2" e2="DrugDDI.d164.s1.e5" interaction="false"/><pair id="DrugDDI.d164.s1.p16" e1="DrugDDI.d164.s1.e2" e2="DrugDDI.d164.s1.e6" interaction="false"/><pair id="DrugDDI.d164.s1.p17" e1="DrugDDI.d164.s1.e2" e2="DrugDDI.d164.s1.e7" interaction="false"/><pair id="DrugDDI.d164.s1.p18" e1="DrugDDI.d164.s1.e3" e2="DrugDDI.d164.s1.e4" interaction="false"/><pair id="DrugDDI.d164.s1.p19" e1="DrugDDI.d164.s1.e3" e2="DrugDDI.d164.s1.e5" interaction="false"/><pair id="DrugDDI.d164.s1.p20" e1="DrugDDI.d164.s1.e3" e2="DrugDDI.d164.s1.e6" interaction="false"/><pair id="DrugDDI.d164.s1.p21" e1="DrugDDI.d164.s1.e3" e2="DrugDDI.d164.s1.e7" interaction="false"/><pair id="DrugDDI.d164.s1.p22" e1="DrugDDI.d164.s1.e4" e2="DrugDDI.d164.s1.e5" interaction="false"/><pair id="DrugDDI.d164.s1.p23" e1="DrugDDI.d164.s1.e4" e2="DrugDDI.d164.s1.e6" interaction="false"/><pair id="DrugDDI.d164.s1.p24" e1="DrugDDI.d164.s1.e4" e2="DrugDDI.d164.s1.e7" interaction="false"/><pair id="DrugDDI.d164.s1.p25" e1="DrugDDI.d164.s1.e5" e2="DrugDDI.d164.s1.e6" interaction="false"/><pair id="DrugDDI.d164.s1.p26" e1="DrugDDI.d164.s1.e5" e2="DrugDDI.d164.s1.e7" interaction="false"/><pair id="DrugDDI.d164.s1.p27" e1="DrugDDI.d164.s1.e6" e2="DrugDDI.d164.s1.e7" interaction="false"/></sentence><sentence id="DrugDDI.d164.s2" origId="s2" text="Tricyclic antidepressants have been reported to blunt the hypotensive effect of systemic clonidine."><entity id="DrugDDI.d164.s2.e0" origId="s2.p33" charOffset="0-25" type="drug" text="tricyclic antidepressants"/><entity id="DrugDDI.d164.s2.e1" origId="s2.p38" charOffset="89-98" type="drug" text="clonidine"/><pair id="DrugDDI.d164.s2.p0" e1="DrugDDI.d164.s2.e0" e2="DrugDDI.d164.s2.e1" interaction="true"/></sentence><sentence id="DrugDDI.d164.s3" origId="s3" text="It is not known whether the concurrent use of these agents with apraclonidine can lead to a reduction in IOP lowering effect."><entity id="DrugDDI.d164.s3.e0" origId="s3.p45" charOffset="64-77" type="drug" text="apraclonidine"/></sentence><sentence id="DrugDDI.d164.s4" origId="s4" text="No data on the level of circulating catecholamines after apraclonidine withdrawal are available."><entity id="DrugDDI.d164.s4.e0" origId="s4.p53" charOffset="57-70" type="drug" text="apraclonidine"/></sentence><sentence id="DrugDDI.d164.s5" origId="s5" text="Caution, however, is advised in patients taking tricyclic antidepressants which can affect the metabolism and uptake of circulating amines."><entity id="DrugDDI.d164.s5.e0" origId="s5.p62" charOffset="48-73" type="drug" text="tricyclic antidepressants"/></sentence><sentence id="DrugDDI.d164.s6" origId="s6" text="An additive hypotensive effect has been reported with the combination of systemic clonidine and neuroleptic therapy."><entity id="DrugDDI.d164.s6.e0" origId="s6.p75" charOffset="82-91" type="drug" text="clonidine"/></sentence><sentence id="DrugDDI.d164.s7" origId="s7" text="Systemic clonidine may inhibit the production of catecholamines in response to insulin-induced hypoglycemia and mask the signs and symptoms of hypoglycemia."><entity id="DrugDDI.d164.s7.e0" origId="s7.p78" charOffset="9-18" type="drug" text="clonidine"/></sentence><sentence id="DrugDDI.d164.s8" origId="s8" text="Since apraclonidine may reduce pulse and blood pressure, caution in using drugs such as beta-blockers (ophthalmic and systemic), antihypertensives, and cardiac glycosides is advised."><entity id="DrugDDI.d164.s8.e0" origId="s8.p92" charOffset="6-19" type="drug" text="apraclonidine"/><entity id="DrugDDI.d164.s8.e1" origId="s8.p101" charOffset="74-79" type="drug" text="drugs"/><entity id="DrugDDI.d164.s8.e2" origId="s8.p102" charOffset="88-102" type="drug" text="beta-blockers"/><entity id="DrugDDI.d164.s8.e3" origId="s8.p109" charOffset="129-146" type="drug" text="antihypertensives"/><entity id="DrugDDI.d164.s8.e4" origId="s8.p111" charOffset="152-170" type="drug" text="cardiac glycosides"/><pair id="DrugDDI.d164.s8.p0" e1="DrugDDI.d164.s8.e0" e2="DrugDDI.d164.s8.e1" interaction="true"/><pair id="DrugDDI.d164.s8.p1" e1="DrugDDI.d164.s8.e0" e2="DrugDDI.d164.s8.e2" interaction="false"/><pair id="DrugDDI.d164.s8.p2" e1="DrugDDI.d164.s8.e0" e2="DrugDDI.d164.s8.e3" interaction="true"/><pair id="DrugDDI.d164.s8.p3" e1="DrugDDI.d164.s8.e0" e2="DrugDDI.d164.s8.e4" interaction="false"/><pair id="DrugDDI.d164.s8.p4" e1="DrugDDI.d164.s8.e1" e2="DrugDDI.d164.s8.e2" interaction="false"/><pair id="DrugDDI.d164.s8.p5" e1="DrugDDI.d164.s8.e1" e2="DrugDDI.d164.s8.e3" interaction="false"/><pair id="DrugDDI.d164.s8.p6" e1="DrugDDI.d164.s8.e1" e2="DrugDDI.d164.s8.e4" interaction="false"/><pair id="DrugDDI.d164.s8.p7" e1="DrugDDI.d164.s8.e2" e2="DrugDDI.d164.s8.e3" interaction="false"/><pair id="DrugDDI.d164.s8.p8" e1="DrugDDI.d164.s8.e2" e2="DrugDDI.d164.s8.e4" interaction="false"/><pair id="DrugDDI.d164.s8.p9" e1="DrugDDI.d164.s8.e3" e2="DrugDDI.d164.s8.e4" interaction="false"/></sentence><sentence id="DrugDDI.d164.s9" origId="s9" text="Patients using cardiovascular drugs concurrently with IOPIDINE 0.5% Ophthalmic Solution should have pulse and blood pressures frequently monitored."><entity id="DrugDDI.d164.s9.e0" origId="s9.p116" charOffset="15-35" type="drug" text="cardiovascular drugs"/><entity id="DrugDDI.d164.s9.e1" origId="s9.p117" charOffset="54-65" type="drug" text="IOPIDINE 0"/><pair id="DrugDDI.d164.s9.p0" e1="DrugDDI.d164.s9.e0" e2="DrugDDI.d164.s9.e1" interaction="true"/></sentence><sentence id="DrugDDI.d164.s10" origId="s10" text="Caution should be exercised with simultaneous use of clonidine and other similar pharmacologic agents"><entity id="DrugDDI.d164.s10.e0" origId="s10.p129" charOffset="53-62" type="drug" text="clonidine"/></sentence><sentence id="DrugDDI.d164.s11" origId="s11" text="."/><sentence id="DrugDDI.d164.s12" origId="s12" text="?"/></document>